7 October 2023
Linklaters advises Theramex (a portfolio company of PAI Partners and Carlyle) on Theramex’s proposed acquisition of Duphaston and Femoston oral menopause drugs from Viatris
Advising firms
Deal team
20 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Daniel Law Lead | Linklaters | Partner | Corporate | London |
| Alex Woodward Lead | Linklaters | Partner | Corporate | London |
| Marly Didizian Lead | Linklaters | Partner | Commercial (Carve-Out) | London |
| Yohan Liyanage Lead | Linklaters | Partner | IP | London |
| Jamie Coomber Lead | Linklaters | Partner | Tax | London |
| Alex Selig | Linklaters | Not stated | Corporate | London |
| Kaiya Kim-Saville | Linklaters | Associate | Corporate | London |
| Asim Ayub | Linklaters | Associate | Corporate | London |
| Tibi Sandu | Linklaters | Associate | Corporate | London |
| Catherine Yuen | Linklaters | Associate | Corporate | New York |
| James Marlow | Linklaters | Not stated | ESG | London |
| Danny Greenland | Linklaters | Associate | Commercial (Carve-Out) | London |
| Rachel Varnam | Linklaters | Associate | Commercial (Carve-Out) | London |
| Stephanie Farrington | Linklaters | Not stated | IP | London |
| Olivia Williams | Linklaters | Associate | IP | London |
| Neil Hoolihan | Linklaters | Partner | Antitrust | Brussels |
| Jonathan Ford | Linklaters | Partner | Antitrust | London |
| Juliane Guderian | Linklaters | Not stated | Antitrust | London |
| Sebastian Plötz | Linklaters | Not stated | Antitrust | Düsseldorf |
| Rohesia Vince | Linklaters | Associate | Tax | London |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- TheramexBuy-side
- Counterparties
- Viatris, Inc. (Sell-side)